img

Global Aminoglycosides Antibiotics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aminoglycosides Antibiotics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
Aminoglycosides Antibiotics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aminoglycosides Antibiotics market is projected to reach US$ 1244.9 million in 2034, increasing from US$ 1051.5 million in 2022, with the CAGR of 2.4% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.
Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.
Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.
Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aminoglycosides Antibiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others

Segment by Application


Hospital
Clinic
Post Care Facility
Government & Military
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Aminoglycosides Antibiotics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Aminoglycosides Antibiotics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Aminoglycosides Antibiotics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Aminoglycosides Antibiotics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Aminoglycosides Antibiotics introduction, etc. Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Aminoglycosides Antibiotics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Aminoglycosides Antibiotics Market Overview
1.1 Aminoglycosides Antibiotics Product Overview
1.2 Aminoglycosides Antibiotics Market Segment by Type
1.2.1 Neomycin
1.2.2 Tobramycin
1.2.3 Gentamicin
1.2.4 Amikacin
1.2.5 Etimicin
1.2.6 Others
1.3 Global Aminoglycosides Antibiotics Market Size by Type
1.3.1 Global Aminoglycosides Antibiotics Market Size Overview by Type (2018-2034)
1.3.2 Global Aminoglycosides Antibiotics Historic Market Size Review by Type (2018-2024)
1.3.3 Global Aminoglycosides Antibiotics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aminoglycosides Antibiotics Sales Breakdown by Type (2018-2024)
1.4.2 Europe Aminoglycosides Antibiotics Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Aminoglycosides Antibiotics Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Aminoglycosides Antibiotics Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Aminoglycosides Antibiotics Sales Breakdown by Type (2018-2024)
2 Global Aminoglycosides Antibiotics Market Competition by Company
2.1 Global Top Players by Aminoglycosides Antibiotics Sales (2018-2024)
2.2 Global Top Players by Aminoglycosides Antibiotics Revenue (2018-2024)
2.3 Global Top Players by Aminoglycosides Antibiotics Price (2018-2024)
2.4 Global Top Manufacturers Aminoglycosides Antibiotics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aminoglycosides Antibiotics Market Competitive Situation and Trends
2.5.1 Aminoglycosides Antibiotics Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Aminoglycosides Antibiotics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics as of 2022)
2.7 Date of Key Manufacturers Enter into Aminoglycosides Antibiotics Market
2.8 Key Manufacturers Aminoglycosides Antibiotics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aminoglycosides Antibiotics Status and Outlook by Region
3.1 Global Aminoglycosides Antibiotics Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Aminoglycosides Antibiotics Historic Market Size by Region
3.2.1 Global Aminoglycosides Antibiotics Sales in Volume by Region (2018-2024)
3.2.2 Global Aminoglycosides Antibiotics Sales in Value by Region (2018-2024)
3.2.3 Global Aminoglycosides Antibiotics Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Aminoglycosides Antibiotics Forecasted Market Size by Region
3.3.1 Global Aminoglycosides Antibiotics Sales in Volume by Region (2024-2034)
3.3.2 Global Aminoglycosides Antibiotics Sales in Value by Region (2024-2034)
3.3.3 Global Aminoglycosides Antibiotics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Aminoglycosides Antibiotics by Application
4.1 Aminoglycosides Antibiotics Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Post Care Facility
4.1.4 Government & Military
4.1.5 Others
4.2 Global Aminoglycosides Antibiotics Market Size by Application
4.2.1 Global Aminoglycosides Antibiotics Market Size Overview by Application (2018-2034)
4.2.2 Global Aminoglycosides Antibiotics Historic Market Size Review by Application (2018-2024)
4.2.3 Global Aminoglycosides Antibiotics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aminoglycosides Antibiotics Sales Breakdown by Application (2018-2024)
4.3.2 Europe Aminoglycosides Antibiotics Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Aminoglycosides Antibiotics Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Aminoglycosides Antibiotics Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Aminoglycosides Antibiotics Sales Breakdown by Application (2018-2024)
5 North America Aminoglycosides Antibiotics by Country
5.1 North America Aminoglycosides Antibiotics Historic Market Size by Country
5.1.1 North America Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Aminoglycosides Antibiotics Sales in Volume by Country (2018-2024)
5.1.3 North America Aminoglycosides Antibiotics Sales in Value by Country (2018-2024)
5.2 North America Aminoglycosides Antibiotics Forecasted Market Size by Country
5.2.1 North America Aminoglycosides Antibiotics Sales in Volume by Country (2024-2034)
5.2.2 North America Aminoglycosides Antibiotics Sales in Value by Country (2024-2034)
6 Europe Aminoglycosides Antibiotics by Country
6.1 Europe Aminoglycosides Antibiotics Historic Market Size by Country
6.1.1 Europe Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Aminoglycosides Antibiotics Sales in Volume by Country (2018-2024)
6.1.3 Europe Aminoglycosides Antibiotics Sales in Value by Country (2018-2024)
6.2 Europe Aminoglycosides Antibiotics Forecasted Market Size by Country
6.2.1 Europe Aminoglycosides Antibiotics Sales in Volume by Country (2024-2034)
6.2.2 Europe Aminoglycosides Antibiotics Sales in Value by Country (2024-2034)
7 Asia-Pacific Aminoglycosides Antibiotics by Region
7.1 Asia-Pacific Aminoglycosides Antibiotics Historic Market Size by Region
7.1.1 Asia-Pacific Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Aminoglycosides Antibiotics Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Aminoglycosides Antibiotics Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Aminoglycosides Antibiotics Forecasted Market Size by Region
7.2.1 Asia-Pacific Aminoglycosides Antibiotics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Aminoglycosides Antibiotics Sales in Value by Region (2024-2034)
8 Latin America Aminoglycosides Antibiotics by Country
8.1 Latin America Aminoglycosides Antibiotics Historic Market Size by Country
8.1.1 Latin America Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Aminoglycosides Antibiotics Sales in Volume by Country (2018-2024)
8.1.3 Latin America Aminoglycosides Antibiotics Sales in Value by Country (2018-2024)
8.2 Latin America Aminoglycosides Antibiotics Forecasted Market Size by Country
8.2.1 Latin America Aminoglycosides Antibiotics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Aminoglycosides Antibiotics Sales in Value by Country (2024-2034)
9 Middle East and Africa Aminoglycosides Antibiotics by Country
9.1 Middle East and Africa Aminoglycosides Antibiotics Historic Market Size by Country
9.1.1 Middle East and Africa Aminoglycosides Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Aminoglycosides Antibiotics Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Aminoglycosides Antibiotics Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Aminoglycosides Antibiotics Forecasted Market Size by Country
9.2.1 Middle East and Africa Aminoglycosides Antibiotics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Aminoglycosides Antibiotics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Jemicare
10.1.1 Jemicare Company Information
10.1.2 Jemicare Introduction and Business Overview
10.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Jemicare Aminoglycosides Antibiotics Products Offered
10.1.5 Jemicare Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Teva Aminoglycosides Antibiotics Products Offered
10.2.5 Teva Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Aminoglycosides Antibiotics Products Offered
10.3.5 Novartis Recent Development
10.4 Fangyuan-pharma
10.4.1 Fangyuan-pharma Company Information
10.4.2 Fangyuan-pharma Introduction and Business Overview
10.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Products Offered
10.4.5 Fangyuan-pharma Recent Development
10.5 Aike Pharmaceutical
10.5.1 Aike Pharmaceutical Company Information
10.5.2 Aike Pharmaceutical Introduction and Business Overview
10.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Products Offered
10.5.5 Aike Pharmaceutical Recent Development
10.6 Cipla
10.6.1 Cipla Company Information
10.6.2 Cipla Introduction and Business Overview
10.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cipla Aminoglycosides Antibiotics Products Offered
10.6.5 Cipla Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Pfizer Aminoglycosides Antibiotics Products Offered
10.7.5 Pfizer Recent Development
10.8 Fresenius Kabi
10.8.1 Fresenius Kabi Company Information
10.8.2 Fresenius Kabi Introduction and Business Overview
10.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Fresenius Kabi Aminoglycosides Antibiotics Products Offered
10.8.5 Fresenius Kabi Recent Development
10.9 Sun Pharma
10.9.1 Sun Pharma Company Information
10.9.2 Sun Pharma Introduction and Business Overview
10.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sun Pharma Aminoglycosides Antibiotics Products Offered
10.9.5 Sun Pharma Recent Development
10.10 Hikma
10.10.1 Hikma Company Information
10.10.2 Hikma Introduction and Business Overview
10.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Hikma Aminoglycosides Antibiotics Products Offered
10.10.5 Hikma Recent Development
10.11 Lannett Company
10.11.1 Lannett Company Company Information
10.11.2 Lannett Company Introduction and Business Overview
10.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Lannett Company Aminoglycosides Antibiotics Products Offered
10.11.5 Lannett Company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aminoglycosides Antibiotics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aminoglycosides Antibiotics Industrial Chain Analysis
11.4 Aminoglycosides Antibiotics Market Dynamics
11.4.1 Aminoglycosides Antibiotics Industry Trends
11.4.2 Aminoglycosides Antibiotics Market Drivers
11.4.3 Aminoglycosides Antibiotics Market Challenges
11.4.4 Aminoglycosides Antibiotics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aminoglycosides Antibiotics Distributors
12.3 Aminoglycosides Antibiotics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Neomycin
Table 2. Major Company of Tobramycin
Table 3. Major Company of Gentamicin
Table 4. Major Company of Amikacin
Table 5. Major Company of Etimicin
Table 6. Major Company of Others
Table 7. Global Aminoglycosides Antibiotics Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Aminoglycosides Antibiotics Sales by Type (2018-2024) & (M Units)
Table 9. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Aminoglycosides Antibiotics Sales by Type (2018-2024) & (US& Million)
Table 11. Global Aminoglycosides Antibiotics Market Share in Value by Type (2018-2024)
Table 12. Global Aminoglycosides Antibiotics Price by Type (2018-2024) & (USD/Unit)
Table 13. Global Aminoglycosides Antibiotics Sales by Type (2024-2034) & (M Units)
Table 14. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Aminoglycosides Antibiotics Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Aminoglycosides Antibiotics Sales Market Share in Value by Type (2024-2034)
Table 17. Global Aminoglycosides Antibiotics Price by Type (2024-2034) & (USD/Unit)
Table 18. North America Aminoglycosides Antibiotics Sales by Type (2018-2024) & (M Units)
Table 19. North America Aminoglycosides Antibiotics Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Aminoglycosides Antibiotics Sales (M Units) by Type (2018-2024)
Table 21. Europe Aminoglycosides Antibiotics Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Aminoglycosides Antibiotics Sales (M Units) by Type (2018-2024)
Table 23. Asia-Pacific Aminoglycosides Antibiotics Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Aminoglycosides Antibiotics Sales (M Units) by Type (2018-2024)
Table 25. Latin America Aminoglycosides Antibiotics Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Aminoglycosides Antibiotics Sales (M Units) by Type (2018-2024)
Table 27. Middle East and Africa Aminoglycosides Antibiotics Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Aminoglycosides Antibiotics Sales by Company (2018-2024) & (M Units)
Table 29. Global Aminoglycosides Antibiotics Sales Share by Company (2018-2024)
Table 30. Global Aminoglycosides Antibiotics Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Aminoglycosides Antibiotics Revenue Share by Company (2018-2024)
Table 32. Global Market Aminoglycosides Antibiotics Price by Company (2018-2024) & (USD/Unit)
Table 33. Global Aminoglycosides Antibiotics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Aminoglycosides Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics as of 2022)
Table 36. Date of Key Manufacturers Enter into Aminoglycosides Antibiotics Market
Table 37. Key Manufacturers Aminoglycosides Antibiotics Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Aminoglycosides Antibiotics Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Aminoglycosides Antibiotics Sales by Region (2018-2024) & (M Units)
Table 41. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Aminoglycosides Antibiotics Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Aminoglycosides Antibiotics Sales Market Share in Value by Region (2018-2024)
Table 44. Global Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 45. Global Aminoglycosides Antibiotics Sales by Region (2024-2034) & (M Units)
Table 46. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Aminoglycosides Antibiotics Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Aminoglycosides Antibiotics Sales Market Share in Value by Region (2024-2034)
Table 49. Global Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 50. Global Aminoglycosides Antibiotics Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Aminoglycosides Antibiotics Sales by Application (2018-2024) & (M Units)
Table 52. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Aminoglycosides Antibiotics Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Aminoglycosides Antibiotics Sales Market Share in Value by Application (2018-2024)
Table 55. Global Aminoglycosides Antibiotics Price by Application (2018-2024) & (USD/Unit)
Table 56. Global Aminoglycosides Antibiotics Sales by Application (2024-2034) & (M Units)
Table 57. Global Aminoglycosides Antibiotics Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Aminoglycosides Antibiotics Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Aminoglycosides Antibiotics Sales Market Share in Value by Application (2024-2034)
Table 60. Global Aminoglycosides Antibiotics Price by Application (2024-2034) & (USD/Unit)
Table 61. North America Aminoglycosides Antibiotics Sales by Application (2018-2024) (M Units)
Table 62. North America Aminoglycosides Antibiotics Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Aminoglycosides Antibiotics Sales by Application (2018-2024) (M Units)
Table 64. Europe Aminoglycosides Antibiotics Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Aminoglycosides Antibiotics Sales by Application (2018-2024) (M Units)
Table 66. Asia-Pacific Aminoglycosides Antibiotics Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Aminoglycosides Antibiotics Sales by Application (2018-2024) (M Units)
Table 68. Latin America Aminoglycosides Antibiotics Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2018-2024) (M Units)
Table 70. Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Aminoglycosides Antibiotics Sales by Country (2018-2024) & (M Units)
Table 72. North America Aminoglycosides Antibiotics Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Aminoglycosides Antibiotics Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Aminoglycosides Antibiotics Sales Market Share in Value by Country (2018-2024)
Table 75. North America Aminoglycosides Antibiotics Sales by Country (2024-2034) & (M Units)
Table 76. North America Aminoglycosides Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Aminoglycosides Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Aminoglycosides Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Aminoglycosides Antibiotics Sales by Country (2018-2024) & (M Units)
Table 80. Europe Aminoglycosides Antibiotics Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Aminoglycosides Antibiotics Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Aminoglycosides Antibiotics Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Aminoglycosides Antibiotics Sales by Country (2024-2034) & (M Units)
Table 84. Europe Aminoglycosides Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Aminoglycosides Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Aminoglycosides Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Aminoglycosides Antibiotics Sales by Region (2018-2024) & (M Units)
Table 88. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Aminoglycosides Antibiotics Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Aminoglycosides Antibiotics Sales by Region (2024-2034) & (M Units)
Table 92. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Aminoglycosides Antibiotics Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Aminoglycosides Antibiotics Sales by Country (2018-2024) & (M Units)
Table 96. Latin America Aminoglycosides Antibiotics Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Aminoglycosides Antibiotics Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Aminoglycosides Antibiotics Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Aminoglycosides Antibiotics Sales by Country (2024-2034) & (M Units)
Table 100. Latin America Aminoglycosides Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Aminoglycosides Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Aminoglycosides Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2018-2024) & (M Units)
Table 104. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2024-2034) & (M Units)
Table 108. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Value by Country (2024-2034)
Table 111. Jemicare Company Information
Table 112. Jemicare Introduction and Business Overview
Table 113. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 114. Jemicare Aminoglycosides Antibiotics Product
Table 115. Jemicare Recent Development
Table 116. Teva Company Information
Table 117. Teva Introduction and Business Overview
Table 118. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 119. Teva Aminoglycosides Antibiotics Product
Table 120. Teva Recent Development
Table 121. Novartis Company Information
Table 122. Novartis Introduction and Business Overview
Table 123. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 124. Novartis Aminoglycosides Antibiotics Product
Table 125. Novartis Recent Development
Table 126. Fangyuan-pharma Company Information
Table 127. Fangyuan-pharma Introduction and Business Overview
Table 128. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 129. Fangyuan-pharma Aminoglycosides Antibiotics Product
Table 130. Fangyuan-pharma Recent Development
Table 131. Aike Pharmaceutical Company Information
Table 132. Aike Pharmaceutical Introduction and Business Overview
Table 133. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 134. Aike Pharmaceutical Aminoglycosides Antibiotics Product
Table 135. Aike Pharmaceutical Recent Development
Table 136. Cipla Company Information
Table 137. Cipla Introduction and Business Overview
Table 138. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 139. Cipla Aminoglycosides Antibiotics Product
Table 140. Cipla Recent Development
Table 141. Pfizer Company Information
Table 142. Pfizer Introduction and Business Overview
Table 143. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 144. Pfizer Aminoglycosides Antibiotics Product
Table 145. Pfizer Recent Development
Table 146. Fresenius Kabi Company Information
Table 147. Fresenius Kabi Introduction and Business Overview
Table 148. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 149. Fresenius Kabi Aminoglycosides Antibiotics Product
Table 150. Fresenius Kabi Recent Development
Table 151. Sun Pharma Company Information
Table 152. Sun Pharma Introduction and Business Overview
Table 153. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 154. Sun Pharma Aminoglycosides Antibiotics Product
Table 155. Sun Pharma Recent Development
Table 156. Hikma Company Information
Table 157. Hikma Introduction and Business Overview
Table 158. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 159. Hikma Aminoglycosides Antibiotics Product
Table 160. Hikma Recent Development
Table 161. Lannett Company Company Information
Table 162. Lannett Company Introduction and Business Overview
Table 163. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 164. Lannett Company Aminoglycosides Antibiotics Product
Table 165. Lannett Company Recent Development
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Aminoglycosides Antibiotics Market Trends
Table 169. Aminoglycosides Antibiotics Market Drivers
Table 170. Aminoglycosides Antibiotics Market Challenges
Table 171. Aminoglycosides Antibiotics Market Restraints
Table 172. Aminoglycosides Antibiotics Distributors List
Table 173. Aminoglycosides Antibiotics Downstream Customers
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Aminoglycosides Antibiotics Product Picture
Figure 2. Global Aminoglycosides Antibiotics Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Aminoglycosides Antibiotics Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Aminoglycosides Antibiotics Sales Status and Outlook (2018-2034) & (M Units)
Figure 5. Product Picture of Neomycin
Figure 6. Global Neomycin Sales YoY Growth (2018-2034) & (M Units)
Figure 7. Product Picture of Tobramycin
Figure 8. Global Tobramycin Sales YoY Growth (2018-2034) & (M Units)
Figure 9. Product Picture of Gentamicin
Figure 10. Global Gentamicin Sales YoY Growth (2018-2034) & (M Units)
Figure 11. Product Picture of Amikacin
Figure 12. Global Amikacin Sales YoY Growth (2018-2034) & (M Units)
Figure 13. Product Picture of Etimicin
Figure 14. Global Etimicin Sales YoY Growth (2018-2034) & (M Units)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (M Units)
Figure 17. Global Aminoglycosides Antibiotics Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Aminoglycosides Antibiotics Sales Market Share by Type in 2022 & 2034
Figure 19. North America Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2022
Figure 20. North America Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2022
Figure 21. Europe Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2022
Figure 22. Europe Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2022
Figure 25. Latin America Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Aminoglycosides Antibiotics Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Aminoglycosides Antibiotics Revenue in 2022
Figure 31. Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (M Units)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (M Units)
Figure 36. Product Picture of Post Care Facility
Figure 37. Global Post Care Facility Sales YoY Growth (2018-2034) & (M Units)
Figure 38. Product Picture of Government & Military
Figure 39. Global Government & Military Sales YoY Growth (2018-2034) & (M Units)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2018-2034) & (M Units)
Figure 42. Global Aminoglycosides Antibiotics Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Aminoglycosides Antibiotics Sales Market Share by Application in 2022 & 2034
Figure 44. North America Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2022
Figure 45. North America Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2022
Figure 46. Europe Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2022
Figure 47. Europe Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2022
Figure 50. Latin America Aminoglycosides Antibiotics Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Aminoglycosides Antibiotics Manufacturing Cost Structure
Figure 55. Aminoglycosides Antibiotics Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries